Ramin Ebrahimi

10.7k total citations · 4 hit papers
164 papers, 5.5k citations indexed

About

Ramin Ebrahimi is a scholar working on Cardiology and Cardiovascular Medicine, Infectious Diseases and Surgery. According to data from OpenAlex, Ramin Ebrahimi has authored 164 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Cardiology and Cardiovascular Medicine, 34 papers in Infectious Diseases and 28 papers in Surgery. Recurrent topics in Ramin Ebrahimi's work include HIV/AIDS drug development and treatment (27 papers), Atrial Fibrillation Management and Outcomes (17 papers) and HIV Research and Treatment (16 papers). Ramin Ebrahimi is often cited by papers focused on HIV/AIDS drug development and treatment (27 papers), Atrial Fibrillation Management and Outcomes (17 papers) and HIV Research and Treatment (16 papers). Ramin Ebrahimi collaborates with scholars based in United States, Germany and United Kingdom. Ramin Ebrahimi's co-authors include Frederick Feit, A. Michael Lincoff, Gregg W. Stone, Naser Ahmadi, Roxana Mehran, Fereshteh Hajsadeghi, Matthew J. Budoff, Steven V. Manoukian, Martial Hamon and Jeffrey W. Moses and has published in prestigious journals such as JAMA, Circulation and Journal of Clinical Oncology.

In The Last Decade

Ramin Ebrahimi

153 papers receiving 5.3k citations

Hit Papers

Bivalirudin and Provisional Glycoprotein IIb/IIIa Blockad... 2003 2026 2010 2018 2003 2007 2007 2023 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ramin Ebrahimi United States 34 2.6k 1.4k 1.3k 1.3k 826 164 5.5k
Philimon Gona United States 42 4.2k 1.6× 426 0.3× 1.4k 1.1× 1.1k 0.8× 221 0.3× 101 7.1k
Murielle Mary‐Krause France 24 1.6k 0.6× 1.0k 0.7× 808 0.6× 1.1k 0.9× 232 0.3× 63 4.0k
Priscilla Y. Hsue United States 47 2.4k 0.9× 2.6k 1.8× 1.8k 1.4× 1.4k 1.1× 50 0.1× 187 9.3k
Matthias Girndt Germany 46 585 0.2× 626 0.4× 1.6k 1.3× 969 0.8× 56 0.1× 195 7.0k
E Janecek Canada 5 723 0.3× 688 0.5× 998 0.8× 1.1k 0.9× 104 0.1× 8 8.5k
C Domecq Canada 3 727 0.3× 685 0.5× 989 0.8× 1.1k 0.9× 104 0.1× 4 8.4k
Paul‐Michel Mertès France 42 1.0k 0.4× 1.6k 1.1× 395 0.3× 1.1k 0.9× 548 0.7× 202 7.5k
Stefan H. Jacobson Sweden 42 962 0.4× 190 0.1× 1.2k 0.9× 1.3k 1.0× 201 0.2× 214 7.1k
D Friès Austria 44 849 0.3× 141 0.1× 698 0.5× 1.7k 1.4× 778 0.9× 303 6.7k
Patrick Commerford South Africa 28 4.0k 1.6× 242 0.2× 1.2k 0.9× 1.3k 1.0× 736 0.9× 66 6.3k

Countries citing papers authored by Ramin Ebrahimi

Since Specialization
Citations

This map shows the geographic impact of Ramin Ebrahimi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ramin Ebrahimi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ramin Ebrahimi more than expected).

Fields of papers citing papers by Ramin Ebrahimi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ramin Ebrahimi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ramin Ebrahimi. The network helps show where Ramin Ebrahimi may publish in the future.

Co-authorship network of co-authors of Ramin Ebrahimi

This figure shows the co-authorship network connecting the top 25 collaborators of Ramin Ebrahimi. A scholar is included among the top collaborators of Ramin Ebrahimi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ramin Ebrahimi. Ramin Ebrahimi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Ebrahimi, Ramin, Fahim Ebrahimi, Jan Hendrik Niess, et al.. (2025). Increased Risk of Cardiovascular Events After Coronary Interventions in Inflammatory Bowel Disease: A Nationwide Matched Cohort Study. Alimentary Pharmacology & Therapeutics. 61(12). 1904–1912. 1 indexed citations
3.
Ebrahimi, Fahim, Ramin Ebrahimi, Marc A. Beer, et al.. (2025). Colchicine for the secondary prevention of cardiovascular events. Cochrane Database of Systematic Reviews. 2025(11). CD014808–CD014808.
4.
Ebrahimi, Ramin, Marco Centola, Felice Achilli, et al.. (2025). Association of sodium–glucose cotransporter-2 inhibitors with mortality across the spectrum of myocardial infarction: a systematic review and meta-analysis. Cardiovascular Diabetology. 24(1). 29–29. 3 indexed citations
5.
Ebrahimi, Ramin, Marcus Dörr, Márcio Galindo Kiuchi, et al.. (2024). 3D Map Combined with Transthoracic Echocardiography for Ablation of Premature Ventricular Contractions/Ventricular Arrhythmia from Papillary Muscle: A Technical Report. Journal of Clinical Medicine. 13(21). 6358–6358.
6.
Urbanek, Lukas, Boris Schmidt, Stefano Bordignon, et al.. (2024). Cryoablation of atrial fibrillation in “very severe” obese patients (BMI ≥ 40): Indications, feasibility, procedural safety and efficacy, and clinical outcome (the ICE‐Obese Extreme). Journal of Cardiovascular Electrophysiology. 35(7). 1412–1421. 4 indexed citations
7.
Preston, Mark, Ramin Ebrahimi, Raj Desai, et al.. (2024). Risk of cardiovascular events following intermittent and continuous androgen deprivation therapy in patients with nonmetastatic prostate cancer. Urologic Oncology Seminars and Original Investigations. 42(12). 447.e1–447.e9. 2 indexed citations
8.
Ebrahimi, Fahim, Ramin Ebrahimi, Hannes Hagström, et al.. (2024). Risk of Major Adverse Cardiovascular Outcomes in Families With MASLD: A Population-Based Multigenerational Cohort Study. Circulation Cardiovascular Quality and Outcomes. 17(11). e010912–e010912. 2 indexed citations
9.
Sohn, Seo Young, Kosuke Inoue, Muhammad Tariq Bashir, et al.. (2024). Thyroid Dysfunction Risk After Iodinated Contrast Media Administration: A Prospective Longitudinal Cohort Analysis. The Journal of Clinical Endocrinology & Metabolism. 110(4). e1204–e1210. 7 indexed citations
10.
Bordignon, Stefano, Ilaria My, Shota Tohoku, et al.. (2023). Efficacy and safety in patients treated with a novel radiofrequency balloon: a two centres experience from the AURORA collaboration. EP Europace. 25(5). 11 indexed citations
11.
Schaack, David, Boris Schmidt, Shota Tohoku, et al.. (2023). Pulsed Field Ablation for Atrial Fibrillation. Arrhythmia & Electrophysiology Review. 12. e11–e11. 17 indexed citations
12.
Tohoku, Shota, Boris Schmidt, David Schaack, et al.. (2023). Impact of Pulsed-Field Ablation on Intrinsic Cardiac Autonomic Nervous System After Pulmonary Vein Isolation. JACC. Clinical electrophysiology. 9(9). 1864–1875. 28 indexed citations
13.
Bishawi, Muath, Brack Hattler, G. Hossein Almassi, et al.. (2022). Health‐related quality of life impacts upon 5‐year survival after coronary artery bypass surgery. Journal of Cardiac Surgery. 37(12). 4899–4905. 2 indexed citations
14.
Tohoku, Shota, K. R. Julian Chun, Stefano Bordignon, et al.. (2022). Findings from repeat ablation using high-density mapping after pulmonary vein isolation with pulsed field ablation. EP Europace. 25(2). 433–440. 57 indexed citations
15.
Thomas, Jordan, Olujimi A. Ajijola, Ramin Ebrahimi, et al.. (2021). Key dimensions of post-traumatic stress disorder and endothelial dysfunction: a protocol for a mechanism-focused cohort study. BMJ Open. 11(5). e043060–e043060. 4 indexed citations
16.
Asatryan, Babken, Ramin Ebrahimi, Ivo Strebel, et al.. (2019). Man vs machine: Performance of manual vs automated electrocardiogram analysis for predicting the chamber of origin of idiopathic ventricular arrhythmia. Journal of Cardiovascular Electrophysiology. 31(2). 410–416. 5 indexed citations
17.
Marcellin, Patrick, E.J. Heathcote, Thomas Berg, et al.. (2011). 739 EFFECTS OF TENOFOVIR DISOPROXIL FUMARATE ON RENAL FUNCTION IN CHRONIC HBV PATIENTS IN THREE GLOBAL RANDOMIZED STUDIES. Journal of Hepatology. 54. S296–S297. 6 indexed citations
18.
Ahmadi, Naser, Irfan Zeb, Panteha Rezaeian, et al.. (2010). Abstract 20824: Aged Garlic Extract Supplemented with B Vitamins, Folic Acid and L-Arginine Reduce the Progression of Adipose Tissue and Coronary Artery Calcium. Circulation. 122. 1 indexed citations
19.
Manoukian, Steven V., Frederick Feit, Michele Voeltz, et al.. (2007). Impact of the ACUITY and TIMI major bleeding definitions on one-year mortality in patients with acute coronary syndromes. Circulation. 116(16). 482–482. 1 indexed citations
20.
Peters, Marion G., Hie‐Won Hann, Paul Martin, et al.. (2003). Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B 1 1The Adefovir Dipivoxil International 461 Study Group includes the following: N. Afdhal (Beth Israel Deaconess Medical Center, Boston, MA); P. Angus (Austin and Repatriation Medical Centre, Melbourne, Australia); Y. Benhamou (Hopital La Pitie Salpetriere, Paris, France); M. Bourliere (Hopital Saint Joseph, Marseille, France); P. Buggisch (Universitaetsklinikum Eppendorf, Department of Medicine, Hamburg, Germany); P. Couzigou (Hopital Haut Leveque, Pessac, France); P. Ducrotte and G. Riachi (Hopital Charles Nicolle, Rouen, France); E. Jenny Heathcote (Toronto Western Hospital, Toronto, Ontario, Canada); H. W. Hann (Jefferson Medical College, Philadelphia, PA); I. Jacobson (New York Presbyterian Hospital, New York, NY); K. Kowdley (University of Washington Hepatology Center, Seattle, WA); P. Marcellin (Hopital Beaujon, Clichy, France); P. Martin (Cedars-Sinai Medical Center, Los Angeles, CA); J. M. Metreau (Centre Hospitalier Universitaire Henri Mondor, Creteil, France); M. G. Peters (University of California, San Francisco, San Francisco, CA); R. Rubin (Piedmont Hospital, Atlanta, GA); S. Sacks (Viridae Clinical Sciences, Inc., Vancouver, Canada); H. Thomas (St. Mary’s Hospital, London, England); C. Trepo (Hopital Hôtel Dieu, Lyon, France); D. Vetter (Hopital Civil, Strasbourg, France); C. L. Brosgart, R. Ebrahimi, J. Fry, C. Gibbs, K. Kleber, J. Rooney, M. Sullivan, P. Vig, C. Westland, M. Wulfsohn, and S. Xiong (Gilead Sciences, Inc., Foster City, CA); D. F. Gray (GlaxoSmithKline, Greenford, Middlesex, England); R. Schilling and V. Ferry (Parexel International, Waltham, MA); and D. Hunt (Covance Laboratories, Princeton, NJ).. Gastroenterology. 126(1). 91–101. 440 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026